Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of Upper-extremity Autologous End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease: ACTIVATE AVF

NCT05462223 is registered in ClinicalTrials.gov with Alucent Biomedical as lead sponsor.

NCT NCT05462223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of Upper-extremity Autologous End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease: ACTIVATE AVF
Lead sponsor
Alucent Biomedical
Phase
Not applicable
Overall status
Unknown status
Start date
July 15, 2022
Completion date
December 15, 2024
Enrollment
30 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

av fistula